EXTL Antibodies

Santa Cruz Biotechnology features a diverse variety of EXTL Antibodies for targeting the EXTL protein family. EXTL Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EXTL proteins are fundamental in the biosynthesis of glycosaminoglycans, which serve as essential components of the extracellular matrix and participate in cell signaling, proliferation, and differentiation. The proper function of EXTL proteins is critical for normal cellular processes, while their dysregulation has been linked to various diseases, including cancer and developmental disorders. Research focusing on EXTL proteins continues to reveal potential therapeutic targets and disease mechanisms. Scientists worldwide utilize EXTL monoclonal antibodies to explore cellular pathways and molecular interactions. Understanding EXTL protein function advances knowledge in developmental biology and disease progression. EXTL monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to scientific discovery and therapeutic development.